Non-interventional Study -Observe Treatment Efficacy in Maintaining Symptoms Control in Schizophrenia With Seroquel XR
NCT ID: NCT00750087
Last Updated: 2010-02-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
578 participants
OBSERVATIONAL
2008-08-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Observation of Change in Clinical Global Impression Scores in Schizophrenia Patients Receiving Seroquel XR Treatment
NCT00758251
SR-Registration Study 1, ROW: Efficacy and Safety of Seroquel® in the Treatment of Patients With Schizophrenia
NCT00206115
Study Evaluating the Clinical Benefit of SEROQUEL XR in Subjects With Schizophrenia
NCT00640601
Seroquel XR in Schizophrenia Relapse Prevention
NCT00990626
Seroquel XR in the Long Term Treatment of Schizophrenia
NCT01202617
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Schizophrenia patients stabilized on Seroquel XR
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All eligible patients will be included in the protocol provided they will receive detailed information in advance and will sign consent to grant access to their own data collected during this programme.
Exclusion Criteria
* As per valid Romanian SmPC, concomitant medication, that could result in drug interactions and could jeopardise patient safety will be carefully considered before having the patient enrolled.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
AstraZeenca
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Beatrice Costea
Role: STUDY_CHAIR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Alba, , Romania
Research Site
Arad, , Romania
Research Site
Bacau, , Romania
Research Site
Baia Mare, , Romania
Research Site
Bistriţa, , Romania
Research Site
Botoșani, , Romania
Research Site
Brasov, , Romania
Research Site
Brăila, , Romania
Research Site
Bucharest, , Romania
Research Site
Câmpina, , Romania
Research Site
Călăraşi, , Romania
Research Site
Cluj-Napoca, , Romania
Research Site
Constanța, , Romania
Research Site
Craiova, , Romania
Research Site
Deva, , Romania
Research Site
Galati, , Romania
Research Site
Giurgiu, , Romania
Research Site
Horezu, , Romania
Research Site
Iași, , Romania
Research Site
Oradea, , Romania
Research Site
Piteşti, , Romania
Research Site
Ploieşti, , Romania
Research Site
Râmnicu Vâlcea, , Romania
Research Site
Satu Mare, , Romania
Research Site
Sibiu, , Romania
Research Site
Siret, , Romania
Research Site
Slatina, , Romania
Research Site
Slobozia, , Romania
Research Site
Târgovişte, , Romania
Research Site
Târgu Mureş, , Romania
Research Site
Timișoara, , Romania
Research Site
Zalău, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NIS-NRO-SER-2008/1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.